A novel counterpulse drive mode of continuous-flow left ventricular assist devices can minimize intracircuit backward flow during pump weaning

Journal of Artificial Organs

Volumn 14, Issue 1, 2011, Pages 74-79

  Ando, Masahiko ^a,b   Nishimura, Takashi ^b   Takewa, Yoshiaki ^a   Ogawa, Daisuke ^e   Yamazaki, Kenji ^d   Kashiwa, Koichi ^c   Kyo, Shunei ^b   Ono, Minoru ^b   Taenaka, Yoshiyuki ^a   Tatsumi, Eisuke ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^d TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^e Sun Medical Technology Research Corporation   (Japan)

Author keywords

Bridge to recovery; Left ventricular assist device; Mock circulation

Indexed keywords

AORTA PRESSURE; ARTICLE; CENTRIFUGATION; CONTROLLED STUDY; COUNTERPULSATION; DEVICE SAFETY; HEART CYCLE; HEART LEFT VENTRICLE PRESSURE; HEART PERFUSION; HEART RATE VARIABILITY; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEMODYNAMIC MONITORING; LEFT VENTRICULAR ASSIST DEVICE; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PULSATILE FLOW; SYSTEMIC CIRCULATION;

HEART-ASSIST DEVICES; HUMANS; MODELS, CARDIOVASCULAR; VENTRICULAR FUNCTION, LEFT; VENTRICULAR PRESSURE;

EID: 79955814193     PISSN: 14347229     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10047-010-0544-6     Document Type: Article

References (9)

1. Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, Sun B, Tatooles AJ, Delgado RM 3rd, Long JW, Wozniak TC, Ghumman W, Farrar DJ, Frazier OH. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361:2241-51.
2. Birks EJ, Tansley PD, Hardy J, George RS, Bowles CT, Burke M, Banner NR, Khaghani A, Yacoub MH. Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med. 2006;355:1873-84. (Pubitemid 44664645)
3. Dandel M, Weng Y, Siniawski H, Potapov E, Drews T, Lehmkuhl HB, Knosalla C, Hetzer R. Prediction of cardiac stability after weaning from left ventricular assist device in patients with idiopathic dilated cardiomyopathy. Circulation. 2008;118:S94-105.
4. Myers TJ, Frazier OH, Mesina HS, Radovancevic B, Gregoric ID. Hemodynamics and patient safety during pump-off studies of an axial-flow left ventricular assist device. J Heart Lung Transplant. 2006;25:379-83.
5. Yamazaki K, Kihara S, Akimoto T, Tagusari O, Kawai A, Umezu M, Tomioka J, Kormos RL, Griffith BP, Kurosawa H. EVAHEART: an implantable centrifugal blood pump for long-term circulatory support. Jpn J Thorac Cardiovasc Surg. 2002;50:461-5. (Pubitemid 38173538)
6. Tayama E, Ohashi Y, Niimi Y, Takami Y, Ohtsuka G, Nakata K, Benkowski R, Glueck JA, Nosé Y. The safety system for the rotary blood pump, combination of the valve and LVAD pulsatile mode: in vitro test. Artif Organs. 1998;22:342-5. (Pubitemid 28188451)
7. Mano A, Nakatani T, Oda N, Kato T, Niwaya K, Tagusari O, Nakajima H, Funatsu T, Hashimoto S, Komamura K, Hanatani A, Ueda IH, Kitakaze M, Kobayashi J, Yagihara T, Kitamura S. Which factors predict the recovery of natural heart function after insertion of a left ventricular assist system? J Heart Lung Transplant. 2008;27:869-74.
8. Weber KT, Janicki JS. Intraaortic balloon counterpulsation. A review of physiological principles, clinical results, and device safety. Ann Thorac Surg. 1974;17:602-36.
9. Yamazaki K, Saito S, Kihara S, Tagusari O, Kurosawa H. Completely pulsatile high flow circulatory support with a constant-speed centrifugal blood pump: mechanisms and early clinical observations. Gen Thorac Cardiovasc Surg. 2007;55:158-62.